Cargando…

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is associated with an increased risk of type 2 diabetes mellitus (T2DM) but its association with prediabetes and T2DM is unknown in Qatar. A cross sectional analysis of 3,017 Qatari subjects from the Qatar Biobank, identified 749 women aged 18–40 years, 720 of whom w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dargham, Soha R., Shewehy, Abeer El, Dakroury, Youssra, Kilpatrick, Eric S., Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827735/ https://www.ncbi.nlm.nih.gov/pubmed/29483674 http://dx.doi.org/10.1038/s41598-018-21987-6

Ejemplares similares

The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population
por: Dargham, Soha R., et al.
Publicado: (2017)

Association of Differing Qatari Genotypes with Vitamin D Metabolites
por: Dakroury, Youssra, et al.
Publicado: (2020)

Qatari Genotype May Contribute to Complications in Type 2 Diabetes
por: Dakroury, Youssra, et al.
Publicado: (2020)

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
por: Al-Hail, Noora, et al.
Publicado: (2019)

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
por: Dawson, Alison J., et al.
Publicado: (2017)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Characterizing epidemiology of prediabetes, diabetes, and hypertension in Qataris: A cross-sectional study
por: Al-Thani, Mohammed H., et al.
Publicado: (2021)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome
por: Gourgari, Evgenia, et al.
Publicado: (2016)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
por: Butler, Alexandra E., et al.
Publicado: (2020)

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
por: Cho, Li-Wei, et al.
Publicado: (2017)

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
por: Kahal, Hassan, et al.
Publicado: (2015)

Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar
por: Humphrey, John M., et al.
Publicado: (2019)

Androstenedione and testosterone levels correlate with in vitro fertilization rates in insulin-resistant women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T(3) in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
por: Pani, Arianna, et al.
Publicado: (2020)

Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
por: Javed, Zeeshan, et al.
Publicado: (2019)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
por: Iskandar, Saadallah, et al.
Publicado: (2019)

Soil Properties Correlate with Microbial Community Structure in Qatari Arid Soils
por: Skariah, Sini, et al.
Publicado: (2023)

microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

Pattern of benign ovarian cysts in Qatari women
por: Zahra, Fatimah
Publicado: (2017)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
por: Ferjan, Simona, et al.
Publicado: (2019)

A Review of the Impact of Bariatric Surgery in Women With Polycystic Ovary Syndrome
por: Lee, Robert, et al.
Publicado: (2020)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome
por: Kirk, Richard J., et al.
Publicado: (2019)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_js2n7lmvvaj8luhjs29tac13d7